H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

The US Department of Health and Human Services (HHS) last week announced funding for a project that will use artificial ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

New analyses extend data on beneficial effects of ibezapolstat on the gut microbiomeConfirmed ibezapolstat's favorable pharmacokinetics showing low systemic exposure and high colonic ...

In the period spanning 2017-2021, a mere 12 new antibiotics entered the market, with only one capable of targeting all the ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

Detailed price information for Citigroup Inc (C-N) from The Globe and Mail including charting and trades.

In general, strive to use antibiotics ... the antibiotic spectrum of treatment after results of cultures and/or susceptibility tests become known. Mild Clostridium difficile infection (CDI ...

diff., a bacterium that can cause serious infections in the colon. Symptoms can range from mild diarrhea and stomach pain to significant colon damage, which can sometimes require surgery. “Antibiotics ...

But now, with bacteria evolving resistance to more and more antibiotics, phage therapy is drawing a second look from researchers—sometimes with a novel twist. Instead of simply using the phages ...

Vancomycin is considereed as a broad-spectrum antibiotic, which means that ... two to eight weeks of the initial infection. “Treatment of C. difficile infection remains in urgent need of agents ...